1800-272-662
Shopping Cart 0
countryflagAU
Login

Adherium Ltd

Healthcare AU ADR

0.002AUD
-(-%)

Last update at 2026-03-13T01:40:00Z

Day Range

0.0020.002
LowHigh

52 Week Range

0.0020.0086
LowHigh

Fundamentals

  • Previous Close 0.002
  • Market Cap10.42M
  • Volume1516666
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-12.34378M
  • Revenue TTM1.12M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM 0.39M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -12.67935M -10.22417M -9.85800M -11.22400M -15.03600M
Minority interest - - - - -
Net income -12.67935M -10.22417M -9.85800M -11.22500M -17.70300M
Selling general administrative 5.49M 5.06M 4.85M 5.36M 6.14M
Selling and marketing expenses 4.29M 2.14M 4.01M 0.94M 0.84M
Gross profit 0.11M 0.27M 2.52M 0.32M -0.02500M
Reconciled depreciation - 0.11M 0.19M 0.18M 0.14M
Ebit -12.53885M -11.67256M -9.85200M -11.22300M -12.80000M
Ebitda -12.43560M -11.56447M -9.66100M -11.04000M -12.65500M
Depreciation and amortization 0.10M 0.11M 0.19M 0.18M 0.14M
Non operating income net other - - - - -
Operating income -12.53885M -12.09340M -9.85200M -11.22300M -12.80000M
Other operating expenses 13.36M 12.93M 15.28M 13.59M 13.80M
Interest expense 0.23M 0.00207M 0.00600M 0.00100M 2.24M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.14M 0.24M 0.20M 0.02M 2.24M
Net interest income - 0.24M 0.20M 0.02M -2.21300M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -1.45045M 1.84M 0.00100M 2.67M
Total revenue 0.82M 0.84M 3.19M 0.53M 0.40M
Total operating expenses 12.65M 12.36M 14.61M 13.38M 13.37M
Cost of revenue 0.71M 0.57M 0.67M 0.21M 0.43M
Total other income expense net -0.14050M 1.87M 1.84M -0.00100M -2.23600M
Discontinued operations - - - - -
Net income from continuing ops - -10.22417M -9.85800M -11.22400M -15.03600M
Net income applicable to common shares -12.67935M -10.22417M -9.85800M -11.22400M -15.03600M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 3.52M 9.89M 12.68M 7.36M 17.04M
Intangible assets 0.00004M - 0.04M 0.00100M 0.00300M
Earning assets - - - - -
Other current assets 1.44M 0.15M 0.23M 0.27M 0.20M
Total liab 8.28M 3.41M 3.47M 3.00M 3.00M
Total stockholder equity -4.76325M 6.48M 9.21M 4.36M 14.04M
Deferred long term liab - - - - -
Other current liab 2.04M - 1.81M 1.21M 1.62M
Common stock 132.13M 131.00M 123.62M 110.52M 110.17M
Capital stock - - 123.62M 110.52M 110.17M
Retained earnings -116.19021M 103.51M -93.28700M -84.60900M -73.38500M
Other liab - - - - -
Good will - - - - -
Other assets - 0.00000M - - -
Cash 0.04M 6.20M 9.08M 5.28M 15.18M
Cash and equivalents - - 9.08M 5.28M 15.02M
Total current liabilities 8.25M 3.36M 3.47M 2.95M 3.00M
Current deferred revenue - 0.57M 0.66M 1.21M 0.69M
Net debt 3.08M -6.10433M -9.03300M -5.19800M -15.17800M
Short term debt 3.12M 0.05M 0.04M 0.04M 0.00000M
Short long term debt - - - - -
Short long term debt total 3.12M 0.09M 0.04M 0.09M -
Other stockholder equity - -249.04563M -21.11600M -21.55000M -22.75200M
Property plant equipment - - 0.13M 0.31M 0.13M
Total current assets 3.40M 9.73M 12.51M 7.05M 16.91M
Long term investments - - - - -
Net tangible assets - - 9.21M 4.36M 14.03M
Short term investments - - - - -
Net receivables 0.08M 1.80M 1.97M 0.42M 0.57M
Long term debt - - - - -
Inventory 1.84M 1.58M 1.24M 1.07M 0.96M
Accounts payable 3.09M 2.75M 0.96M 1.70M 0.70M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -20.70782M 21.01M -21.11600M -21.55000M -22.75200M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.00026M - - -
Deferred long term asset charges - - - - -
Non current assets total 0.12M 0.16M 0.17M 0.31M 0.13M
Capital lease obligations - - 0.04M 0.09M -
Long term debt total - - 0.00000M 0.04M 0.00000M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - -0.00004M -0.04100M -0.27900M -0.02900M
Change to liabilities - - 0.34M 0.05M -0.26800M
Total cashflows from investing activities -0.04819M -0.00004M -0.04100M -0.27900M -0.02900M
Net borrowings - - - - 3.00M
Total cash from financing activities 3.87M 7.73M 13.07M 1.43M 21.90M
Change to operating activities - - - - -
Net income -12.67935M -10.22417M -9.85800M -10.04400M -15.03600M
Change in cash -6.15428M -2.87972M 3.79M -9.89500M 10.59M
Begin period cash flow 6.20M 9.08M 5.28M 15.18M 4.58M
End period cash flow 0.04M 6.20M 9.08M 5.28M 15.18M
Total cash from operating activities -9.98370M -10.61301M -9.27800M -9.61000M -11.27300M
Issuance of capital stock - 8.37M 13.81M - 19.87M
Depreciation 0.10M 0.11M 0.19M 0.19M 0.14M
Other cashflows from investing activities - 0.00000M - - -
Dividends paid - - - - 20.94M
Change to inventory -0.22917M -0.35266M -0.14700M -0.14400M 0.15M
Change to account receivables 0.18M -0.08797M -0.30200M -1.18500M -0.00100M
Sale purchase of stock - -0.64199M -0.74400M 0.00000M -0.96800M
Other cashflows from financing activities - -0.00004M -0.04100M -0.27900M -0.02900M
Change to netincome - - 0.50M 1.53M 3.22M
Capital expenditures 0.05M 0.00004M 0.04M 0.28M 0.03M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 2.46M -0.81847M -0.10900M -1.28000M -0.11900M
Stock based compensation 16.32M - 0.52M 1.50M 0.53M
Other non cash items -16.18967M 0.43M 0.42M 3.76M 4.15M
Free cash flow -10.03189M -10.61305M -9.31900M -9.88900M -11.30200M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ADR
Adherium Ltd		 - -% 0.002 - - 9.32 6.59 9.93 -0.2011
COH
Cochlear Ltd		 -4.74 2.65% 174.42 33.10 26.39 4.88 6.04 5.59 23.13
4DX
4DMEDICAL Ltd		 -0.15 3.55% 4.07 - - 401.92 37.59 417.71 -7.2899
AVR
Anteris Technologies Global Corp		 - -% 9.10 - - 475.96 166.77 334.65 -5.1986
PNV
Polynovo Ltd		 - -% 0.94 94.00 30.21 4.66 7.81 4.68 93.96

Reports Covered

Stock Research & News

View All

Profile

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides Hailie Smartinhaler sensors; Hailie Solution; and Hailie Remote Patient Monitoring (RPM) Solution. The company was founded in 2001 and is based in Melbourne, Australia.

Adherium Ltd

447 Collins Street, Melbourne, VIC, Australia, 3000

Key Executives

Name Title Year Born
Mr. Rick Legleiter B.S., M.B.A. Chief Exec. Officer 1959
Mr. Geoff Feakes Chief Technology Officer NA
Mr. Rob Turnbull B.Com., C.A., B.Com, CA. GM & Joint Company Sec. 1967
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP Joint Company Sec. 1964
Mr. Daniel Kaplon Chief Financial Officer NA
Ms. Kirsty Rutledge-Malyon HR Mang. NA
Ms. Maggie Scott Head of Clinical Operations NA
Mr. Michael Motion Consultant NA
Dr. John Douglas Wilson Exec. Medical Director 1937
Mr. Louis James Panaccio BEC, C.A., M.A.I.C.D. Executive Chairman of the Board 1957

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.